Abstract
In response to DNA damage, eukaryotic cells initiate a complex signalling pathway, termed the DNA damage response (DDR), which coordinates cell cycle arrest with DNA repair. Studies have shown that oncogene-induced senescence, which provides a barrier to tumour development, involves activation of the DDR. Using a genome-wide RNA interference (RNAi) screen, we have identified 17 factors required for oncogenic BRAF to induce senescence in primary fibroblasts and melanocytes. One of these factors is an F-box protein, FBXO31, a candidate tumour suppressor encoded in 16q24.3, a region in which there is loss of heterozygosity in breast, ovarian, hepatocellular and prostate cancers. Here we study the cellular role of FBXO31, identify its target substrate and determine the basis for its growth inhibitory activity. We show that ectopic expression of FBXO31 acts through a proteasome-directed pathway to mediate the degradation of cyclin D1, an important regulator of progression from G1 to S phase, resulting in arrest in G1. Cyclin D1 degradation results from a direct interaction with FBXO31 and is dependent on the F-box motif of FBXO31 and phosphorylation of cyclin D1 at Thr 286, which is known to be required for cyclin D1 proteolysis. The involvement of the DDR in oncogene-induced senescence prompted us to investigate the role of FBXO31 in DNA repair. We find that DNA damage induced by gamma-irradiation results in increased FBXO31 levels, which requires phosphorylation of FBXO31 by the DDR-initiating kinase ATM. RNAi-mediated knockdown of FBXO31 prevents cells from undergoing efficient arrest in G1 after gamma-irradiation and markedly increases sensitivity to DNA damage. Finally, we show that a variety of DNA damaging agents all result in a large increase in FBXO31 levels, indicating that induction of FBXO31 is a general response to genotoxic stress. Our results reveal FBXO31 as a regulator of the G1/S transition that is specifically required for DNA damage-induced growth arrest.
MeSH Terms
Acetylcysteine/analogs & derivatives,pharmacology
Ataxia Telangiectasia Mutated Proteins
Cell Cycle Proteins/metabolism
Cell Line, Tumor
Cyclin D1/metabolism
Cysteine Proteinase Inhibitors/pharmacology
DNA Damage/drug effects,genetics
DNA-Binding Proteins/metabolism
F-Box Proteins/metabolism
G1 Phase/physiology
Humans
Melanoma/genetics,physiopathology
Proteasome Endopeptidase Complex/metabolism
Protein Serine-Threonine Kinases/metabolism
Transcriptional Activation
Tumor Suppressor Proteins/metabolism
Ubiquitination
Chemicals
Cell Cycle Proteins
Cysteine Proteinase Inhibitors
DNA-Binding Proteins
F-Box Proteins
FBXO31 protein, human
Tumor Suppressor Proteins
lactacystin
Cyclin D1
ATM protein, human
Ataxia Telangiectasia Mutated Proteins
Protein Serine-Threonine Kinases
Proteasome Endopeptidase Complex
Acetylcysteine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Santra Manas K
Howard Hughes Medical Institute, Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
Wajapeyee Narendra
Green Michael R
References (23)
23 references, click to expand
-
An elaborate pathway required for Ras-mediated epigenetic silencing.
Nature. 2007 Oct 25;449(7165):1073-7
PMID: 17960246
-
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.
Science. 2007 May 25;316(5828):1160-6
PMID: 17525332
-
Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
Genes Dev. 1997 Apr 15;11(8):957-72
PMID: 9136925
-
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
Science. 1998 Sep 11;281(5383):1677-9
PMID: 9733515
-
Cell cycle checkpoints: preventing an identity crisis.
Science. 1996 Dec 6;274(5293):1664-72
PMID: 8939848
-
Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.
Cell. 2000 Jul 7;102(1):55-66
PMID: 10929713
-
Deletion mapping of chromosome 16q24 in hepatocellular carcinoma in Taiwan and mutational analysis of the 17-beta-HSD gene localized to the region.
Int J Cancer. 2001 Jul 1;93(1):74-9
PMID: 11391624
-
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.
Mol Cancer. 2007 Apr 02;6:24
PMID: 17407548
-
The DNA damage response: putting checkpoints in perspective.
Nature. 2000 Nov 23;408(6811):433-9
PMID: 11100718
-
Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
Prostate. 2005 Feb 15;62(3):267-74
PMID: 15389780
-
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
Genes Dev. 2007 Jan 1;21(1):43-8
PMID: 17210786
-
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.
Cell. 2008 Feb 8;132(3):363-74
PMID: 18267069
-
Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.
Am J Hum Genet. 2003 Oct;73(4):748-67
PMID: 13680524
-
A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.
PLoS One. 2006 Dec 27;1:e128
PMID: 17205132
-
F-box proteins: the key to protein degradation.
J Biomed Sci. 2006 Mar;13(2):181-91
PMID: 16463014
-
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
Nature. 2006 Nov 30;444(7119):638-42
PMID: 17136094
-
Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression.
J Biol Chem. 2004 Oct 1;279(40):41504-11
PMID: 15277517
-
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.
Cancer Res. 2005 Dec 15;65(24):11304-13
PMID: 16357137
-
The ATM-mediated DNA-damage response: taking shape.
Trends Biochem Sci. 2006 Jul;31(7):402-10
PMID: 16774833
-
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
Nature. 2006 Nov 30;444(7119):633-7
PMID: 17136093
-
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables.
Cancer Genet Cytogenet. 2000 Oct 1;122(1):49-54
PMID: 11104033
-
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
Genes Dev. 1998 Nov 15;12(22):3499-511
PMID: 9832503
-
Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.
Mol Cell. 2006 Nov 3;24(3):355-66
PMID: 17081987